New guidelines endorse the use of continuous glucose monitors and insulin pumps in hospital settings, potentially improving glycemic control while reducing hypoglycemia risk in noncritically ill patients.

CBTI offers a non-pharmacological approach to treating insomnia, focusing on behavioral changes that can lead to long-term improvements in sleep quality.

Clinicians treating cancer and kidney disease patients prescribed antidepressants at rates similar to outpatient psychiatrists, highlighting the prevalence of depression management across specialties.

Recent studies show cannabis use before intercourse helped 67% of women with orgasmic dysfunction achieve improved sexual satisfaction, highlighting its potential as a therapeutic option for female sexual health.

CoQ10 supplementation may be particularly relevant for patients on certain medications that reduce its levels in the body, such as statins, beta-blockers, and some antidepressants.

Zunveyl, a prodrug of galantamine, has been formulated to minimize gastrointestinal absorption, potentially addressing common tolerability issues associated with acetylcholinesterase inhibitors in Alzheimer’s treatment.